Two-Week Course of Sleep Aid Increases Adherence in OSA Patients

New research suggests that patients newly diagnosed with obstructive sleep apnea (OSA) who use a short-course of the sleep aid, eszopiclone, when beginning continuous positive airway pressure therapy, are more adherent with therapy in six months.
EurekAlert!